Cas:40193-72-4 (1,2-dibromo-1,2,2-trifluoroethyl)benzene manufacturer & supplier

We serve Chemical Name:(1,2-dibromo-1,2,2-trifluoroethyl)benzene CAS:40193-72-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(1,2-dibromo-1,2,2-trifluoroethyl)benzene

Chemical Name:(1,2-dibromo-1,2,2-trifluoroethyl)benzene
CAS.NO:40193-72-4
Synonyms:(1,2-Dibromotrifluoroethyl)benzene;1,2-Dibromo-1,2,2-trifluoro-1-phenylethane;PC6028
Molecular Formula:C8H5Br2F3
Molecular Weight:317.92900
HS Code:2903999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:315.87100
LogP:4.19150

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (1,2-Dibromotrifluoroethyl)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,PC6028 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2-Dibromo-1,2,2-trifluoro-1-phenylethane Use and application,1,2-Dibromo-1,2,2-trifluoro-1-phenylethane technical grade,usp/ep/jp grade.


Related News: The all-in-one platform provides access to specialists in the fields of leadership, diversity, inclusion and belonging, sleep, nutrition, parenting, and more – to optimize and accelerate personal growth and professional development in support of a person’s whole health, at work and in life. methyl 3-[(4-methoxyphenethyl)-(3-aminobenzenesulfonyl)-amino]-propionate manufacturers creating a Good Practice Exchange to develop, test and evaluate ways to ensure the right culture is created within the academic community, including to support and develop talent, tackle bullying and harassment and promote a system in which diversity of people and ideas can thrive (E)-3-(benzylthio)-2-(2-(benzylthio)vinyl)benzo[b]thiophene suppliers The CHMP has agreed on an update of recommendations for monitoring patients. Healthcare professionals should now check their patients for signs of blood cancers at least once a year for 15 years.1 L-Leucine, N-(3,5-dinitrophenyl)-, heptyl ester vendor & factory.